Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Posted on behalf of Research Services

The Central University Research Ethics Committee (CUREC) has recently approved revisions to the documentation requested from researchers submitting `CUREC 3’ applications to the Medical Sciences Inter-Divisional Research Ethics Committee (MS IDREC) for review.  CUREC 3 applications are required for research involving the administration of any licensed drug or other (non-drug) substances to healthy volunteers in the EU.

The updated review process has been designed to improve the efficiency of the ethical review process, and henceforth researchers will solely be required to complete a single, combined CUREC 3 Protocol/Application form (replacing the need for multiple forms and a protocol to be submitted, as was previously required, and therefore streamlining the process for applicants).

With effect from 21st November 2016, all CUREC 3 applications must be made on the new form.  This should be submitted, to the Clinical Trials and Research Governance (CTRG) team in order for them to ascertain that appropriate insurance cover can be provided for the study and agree that the University can act as the Sponsor of the study.  Once CTRG have confirmed Sponsorship, then the application can be submitted to the MS IDREC for ethical review.

The new form may be downloaded from http://www.admin.ox.ac.uk/curec/apply/ms-idrec-process/#d.en.169855.

Further information may be obtained from Dr Helen Barnby-Porritt, Secretary to MS IDREC, email ethics@medsci.ox.ac.uk